Elevated cerebrospinal fluid neurofilament light protein concentrations predict the development of AIDS dementia complex

Journal of Infectious Diseases

Volumn 195, Issue 12, 2007, Pages 1774-1778

  Gisslén, Magnus ^a,e   Hagberg, Lars ^a   Brew, Bruce J ^b   Cinque, Paola ^c   Price, Richard W ^d   Rosengren, Lars ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c SAN RAFFAELE HOSPITAL   (Italy)

^d SAN FRANCISCO GENERAL HOSPITAL   (United States)

^e SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

NEOPTERIN; NEUROFILAMENT LIGHT PROTEIN; NEUROFILAMENT PROTEIN; UNCLASSIFIED DRUG; VIRUS RNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; AXONAL INJURY; CD4 LYMPHOCYTE COUNT; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; HUMAN; MALE; PREDICTION; PRIORITY JOURNAL; PROTEIN CEREBROSPINAL FLUID LEVEL;

AIDS DEMENTIA COMPLEX; BIOLOGICAL MARKERS; COHORT STUDIES; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NEOPTERIN; NEUROFILAMENT PROTEINS; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; RNA, VIRAL; TIME FACTORS;

EID: 34249904114     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/518043     Document Type: Article

References (15)

1. Sacktor N. The epidemiology of human immunodeficiency virus-associated neurological disease in the era of highly active antiretroviral therapy. J Neurovirol 2002; 8(Suppl 2):115-21.
2. d'Arminio Monforte A, Cinque P, Mocroft A, et al. Changing incidence of central nervous system diseases in the EuroSIDA cohort. Ann Neurol 2004; 55:320-8.
3. Rosengren LE, Karlsson JE, Karlsson JO, Persson LI, Wikkelso C. Patients with amyotrophic lateral sclerosis and other neurodegenerative diseases have increased levels of neurofilament protein in CSF. J Neurochem 1996; 67:2013-8.
4. Abdulle S, Mellgren A, Brew BJ, et al. CSF neurofilament protein (NFL) - a marker of active HIV-related neurodegeneration. J Neurol 2007; 10 April (electronically published ahead of print).
5. Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus-type 1 (HIV-1) infection: report of a working group of the American Academy of Neurology AIDS Task Force. Neurology 1991; 41:778-85.
6. Price RW, Brew BJ. The AIDS dementia complex. J Infect Dis 1988; 158:1079-83.
7. Hagberg L, Andersson L-M, Abdulle S, Gisslen M. Clinical application of cerebrospinal fluid neopterin concentrations in HIV infection. Pteridines 2004; 15:102-6.
8. Dore GJ, McDonald A, Li Y, Kaldor JM, Brew BJ. Marked improvement in survival following AIDS dementia complex in the era of highly active antiretroviral therapy. AIDS 2003; 17:1539-45.
9. Cinque P, Robertson K, Antinori A, Price RW. Neurological complications of HIV infection and AIDS: current and future perspectives. J Neurovirol 2005; 11(Suppl 3):1-5.
10. Cysique LA, Maruff P, Brew BJ. Prevalence and pattern of neuropsychological impairment in human immunodeficiency virus-infected/acquired immunodeficiency syndrome (HIV/AIDS) patients across preand post-highly active antiretroviral therapy eras: a combined study of two cohorts. J Neurovirol 2004; 10:350-7.
11. Sevigny JJ, Albert SM, McDermott MP, et al. Evaluation of HIV RNA and markers of immune activation as predictors of HIV-associated dementia. Neurology 2004; 63:2084-90.
12. Ellis RJ, Moore DJ, Childers ME, et al. Progression to neuropsychological impairment in human immunodeficiency virus infection predicted by elevated cerebrospinal fluid levels of human immunodeficiency virus RNA. Arch Neurol 2002; 59:923-8.
13. Gisslen M, Fuchs D, Svennerholm B, Hagberg L. Cerebrospinal fluid viral load, intrathecal immunoactivation, and cerebrospinal fluid monocytic cell count in HIV-1 infection. J Acquir Immune Defic Syndr 1999; 21:271-6.
14. Brew BJ, Dunbar N, Pemberton L, Kaldor J. Predictive markers of AIDS dementia complex: CD4 cell count and cerebrospinal fluid concentrations of β2-microglobulin and neopterin. J Infect Dis 1996; 174:294-8.
15. Hoffman PN, Cleveland DW, Griffin JW, Landes PW, Cowan NJ, Price DL. Neurofilament gene expression: a major determinant of axonal caliber. Proc Natl Acad Sci USA 1987; 84:3472-6.